Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 201,643 | 226,548 | 129,793 | 185,709 | 53,889 |
| Marketable Securities | 714,967 | 692,818 | 770,579 | 911,700 | 499,046 |
| Receivables | 218,871 | 6,824 | 9,699 | 2,365 | 2,500 |
| Other current assets | 22,855 | 13,516 | 13,160 | 11,677 | 5,735 |
| TOTAL | $1,174,389 | $950,639 | $946,923 | $1,135,220 | $570,536 |
| Non-Current Assets | |||||
| PPE Net | 378,584 | 382,515 | 381,048 | 384,803 | 387,069 |
| Intangibles | 6,436 | 6,861 | 7,286 | 7,711 | 8,137 |
| Other Non-Current Assets | 44,772 | 45,280 | 45,355 | 45,764 | 47,952 |
| TOTAL | $429,792 | $434,656 | $433,689 | $438,278 | $443,158 |
| Total Assets | $1,604,181 | $1,385,295 | $1,380,612 | $1,573,498 | $1,013,694 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 40,000 | 40,000 | 40,000 | 65,000 | 1,625 |
| Accounts payable and accrued liabilities | 32,937 | 17,674 | 33,050 | 9,980 | 14,457 |
| Accrued Expenses | 144,351 | 117,314 | 84,116 | 95,063 | 70,676 |
| Other current liabilities | 10,675 | 10,811 | 7,375 | 448 | 440 |
| TOTAL | $347,425 | $195,487 | $194,530 | $220,541 | $93,758 |
| Non-Current Liabilities | |||||
| Long Term Debt | 163,108 | 214,883 | 200,332 | 208,927 | 407,789 |
| Deferred Revenues | 111,933 | 2,399 | 22,979 | 43,268 | N/A |
| Other Non-Current Liabilities | 479,695 | 431,638 | 469,355 | 462,387 | 458,205 |
| TOTAL | $694,059 | $686,392 | $666,276 | $668,732 | $863,861 |
| Total Liabilities | $1,041,484 | $881,879 | $860,806 | $889,273 | $957,619 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 140,032 | 135,810 | 138,258 | 138,100 | 126,098 |
| Common Shares | 233 | 231 | 230 | 230 | 218 |
| Retained earnings | -1,596,343 | -1,627,154 | -1,603,404 | -1,428,163 | -1,798,608 |
| Other shareholders' equity | 781 | 43,614 | 2,850 | 5,294 | 7,623 |
| TOTAL | $562,697 | $503,416 | $519,806 | $684,225 | $56,075 |
| Total Liabilities And Equity | $1,604,181 | $1,385,295 | $1,380,612 | $1,573,498 | $1,013,694 |